Skip to content
The Longevity Archive
Elecoglipron in all countries

Legal status · Canada

Is Elecoglipron legal in Canada?

InvestigationalMetabolicEvidence: Moderate

No. Elecoglipron is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Elecoglipron in Canada at a glance

ClassificationInvestigational, not approved
Health Canada approval statusNot approved by Health Canada; investigational
Evidence levelModerate (research strength: Moderate)
ReviewedSep 2026

Classification and note come from the Elecoglipron profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.

What this means

  • 01

    Elecoglipron is being studied in registered clinical trials but has not received Health Canada marketing approval in Canada.

  • 02

    Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.

What Elecoglipron is

AstraZeneca's once-daily oral GLP-1 pill, 10.5% weight loss at 26 weeks in Phase 2b, now entering a broad Phase 3 program.

Elecoglipron is a non-peptide GLP-1 receptor agonist licensed from Eccogene. 6% on placebo, published in The Lancet and presented at ADA 2026.

Mechanism: Small-molecule agonism of the GLP-1 receptor taken orally once a day.

Regulatory history: Investigational; Phase 3 announced 2026

How Health Canada treats this kind of product

Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.

The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Elecoglipron at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

Elecoglipron in other countries

Frequently asked questions

Is Elecoglipron legal in Canada?

No. Elecoglipron is not approved for any medical use in Canada; its classification is "Investigational, not approved". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.

Can I buy Elecoglipron in Canada?

No approved product exists to buy. In Canada Elecoglipron is classified as "Investigational, not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is Elecoglipron Health Canada approved?

No. In Canada Elecoglipron is classified as "Investigational, not approved", which is not a Health Canada marketing approval. For comparison, the US FDA status is: Investigational; Phase 3 announced 2026. Evidence level: Moderate.

Related compounds in Canada

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for Elecoglipron live on its compound profile.

Elecoglipron profile

This page is general information about the regulatory status of Elecoglipron in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.